K2M, a spinal device company, has received 510(k) clearance from the U.S. Food and Drug Administration to market its EVEREST Degenerative Spinal System, according to a company news release.
Spinal Tech
Wright Medical Group has launched its FUSIONFLEX Demineralized Moldable Scaffold, according to a company news release.
Johnson & Johnson’s $21.3 billion acquisition of Synthes may drive its orthopedic device rivals Zimmer and Stryker to make their own deals, according to a report by Bloomberg.
Biomet, a device company focused on the manufacturing of orthopedic products, has received FDA clearance for its Active Articulation E1 Dual Mobility Hip System, according to a company news release.
Johnson & Johnson and Synthes have entered into a definitive agreement, in which Johnson & Johnson will acquire Synthes for $21.3 billion, according to a company news release.
Advertisement
Joseph Burkhardt, DO, of Brookside Surgery Center in Battle Creek, Mich., will be participating in a 10-year follow-up trial of the ConforMIS iUni G2 knee resurfacing device, according to a report from Genetic Engineering & Biotechnology News.
Stryker's President and CEO Stephen P. MacMillan recently discussed the recruitment of global employees, saying new additions to the American workforce aren't stacking up to their international counterparts, according to a Kalamazoo Gazette news report.
The U.S. Food and Drug Administration has approved a major modification to SI-BONE's iFuse Implant System, according to a company news release.
MiMedx has announced it will be featuring two technologies focused on spinal surgery at the upcoming SAS — The International Society for the Advancement of Spine Surgery Annual Meeting, according to a company news release.
Saint Anne's Hospital, a Caritas Health Care facility located in Fall River, Mass., is the only healthcare provider in Massachusetts to provide the MAKOplasty technology for partial joint resurfacing, according to a hospital news release.